Agendia, Inc., a commercial stage company focused on enabling optimized decision-making by providing physicians with next-generation diagnostic and information solutions that can be used to help improve
AI solution will expand Agendia's testing platform in the Brazilian breast cancer market Digital MammaPrint offers fast turnaround time to molecular diagnostics, delivering actionable information
Agendia, Inc., a commercial stage company focused on precision oncology for breast cancer, today announced the appointment of healthcare industry veterans Suja Chandrasekaran, MS and Scott Mendel,
Additional research from the real-world FLEX Registry focuses on age effect and lymph node status for patients with breast cancer Agendia, Inc., a world leader in precision oncology for breast
Data signal importance of serial genomic testing in order to appropriately adjust breast cancer treatment plans Agendia, Inc., a world leader in precision oncology for breast cancer, today shared